Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuyen Ba Tran

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Pharmaceutica Sinica. B|April 3, 2025
Size-transformable nanotherapeutics for cancer therapyTeng Ma, Tuyen Ba Tran, Ethan Lin, et al.
Biomaterials|February 3, 2024
Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Communications|November 9, 2023
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Cancer|August 21, 2025
A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancerZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Pharmaceutica Sinica. B|April 3, 2025
Size-transformable nanotherapeutics for cancer therapyTeng Ma, Tuyen Ba Tran, Ethan Lin, et al.
Biomaterials|February 3, 2024
Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Communications|November 9, 2023
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Cancer|August 21, 2025
A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancerZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Pageof 1